A controlled clinical trial to evaluate a protected environment and prophylactic antibiotic program in the treatment of adult acute leukemia.
D000208:Acute Disease; D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D004780:Environment, Controlled; D006801:Humans; D007263:Infusions, Parenteral; D007938:Leukemia / Q000401:mortality / Q000628:therapy*; D008875:Middle Aged; D012075:Remission, Spontaneous
D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents